A new era in metabolic research studies? How technological advances are reshaping clinical trials

Around the world, a high number of diabetes clinical trials, as well as other metabolic-based studies, are either planned or already underway. In part, this reflects the growing scientific interest in diabetes. But it is also a response to a range of new, emerging technologies and products that are making it faster and easier than ever to run accurate, diverse, and patient-centred decentralized clinical trials (DCTs).

Understanding the growing use and importance of connected devices

Connected devices for clinical studies – such as continuous glucose monitors, smart watches, smart phones, oximeters, and more – are bringing new possibilities to research teams. Woodley Trial Solutions is proud to be able to lend its supply and logistics capabilities to ensure they reach the frontline of research as quickly and smoothly as possible.

By safely collecting, storing, and transmitting data from patients participating in DCTs, these devices harness almost universal internet access in developed markets like North America, the UK, and the European Union to positively transform research practices.

Firstly, by enabling a patient-centred approach to dominate protocols and methodologies, they place patient care firmly at the forefront of research efforts.

Secondly, patient diversity is hugely enhanced, with DCTs offering the scope to take research projects into different communities and harder-to-reach areas that have traditionally found themselves excluded due to a range of socio-economic reasons.

And CROs are also able to access real-time data at previously unprecedented speeds. In turn, this facilitates frequent checks as to how each patient is reacting to the trial – reinforcing Woodley Trial Solutions’ own commitment to always put the patient first in everything we do.

Unlocking new possibilities for diabetes clinical trials

Woodley Trials Solutions supplier Keto-Mojo is an early adopter of device connectivity for clinical trials, designing, iterating, and manufacturing technologies such as the Keto-Mojo Meter. The meter measures glucose and ketone readings on two separate strips, enabling it to produce an accurate Glucose Ketone Index (GKI) number that reveals the patient’s precise state of ketosis.

First released in 2020, this blood glucose and ketone meter is equipped with a Bluetooth connection that facilitates the seamless and real-time transfer of data directly to the patients’ phone. From there, CROs can remotely access the data through a secure connection to the MyMojoHealth platform – directly avoiding any potential window of error or miscommunication in results reporting.

The MyMojoHealth platform can be integrated with a large range of electronic medical records (EMRs) and health apps (including Epic, Validic, and Apple Health), and is approved and available in the USA, Canada, UK, and EU.

“The integration of our Keto-Mojo Meter with the MyMojoHealth platform enables remote patient monitoring, empowering physicians to make real-time informed treatment decisions,” says Dorian Greenow, president and co-founder of Keto-Mojo. “By providing real-time data, we aim to support patient adherence and engagement, ultimately contributing to better patient outcomes in metabolic health.”

Keto-Mojo is a recognised and trusted partner in the ketogenic and metabolic community. As well as diabetes clinical trials, the company’s technologies have also been used in projects focused on metabolic psychiatry, polycystic ovary syndrome, cancer, epilepsy, and athletic performance.

Hennah Patel, Woodley Trial Solutions’ CGM Operations Manager, says: “Advancing medical research and enhancing patient outcomes are two of our central missions. We’re delighted to be able to supply such high quality BGM and BKM connected devices into clinical research.”

Trusted partners for your next research project

For 35 years, Woodley Trial Solutions has been proud to offer exceptional service, innovation, and expertise. Our partnerships with suppliers like Keto-Mojo enable us to build trusted relationships with CROs and sponsors in Europe, North America, and beyond.

At the same time, our range of high-quality connected device' availability complements our range of reliable laboratory and medical equipment to eliminate supply headaches and make us the ideal study partner.

Today, patients living with diabetes (or any other metabolic-based disease) know that medical research and understanding is advancing faster than at any point in history. We’re proud to play our part in this ongoing development and look forward to supporting diabetes clinical trials all over the world that aim to transform the treatment landscape and deliver consistently better patient outcomes.

Running a clinical trial? Contact our friendly team today to discuss your next requirements and make sure your trial proceeds without delay.